NCT03485859

Brief Summary

There have been no studies exploring the efficacy of incision support using an elastic abdominal binder after laparoscopy to date. The investigators performed therefore a randomized controlled trial to determine the effect of post-laparoscopic abdominal binder use on enhanced recovery after surgery (ERAS) in patients with gynecologic disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 2, 2018

Completed
18 days until next milestone

Study Start

First participant enrolled

April 20, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2018

Completed
Last Updated

April 3, 2019

Status Verified

April 1, 2019

Enrollment Period

4 months

First QC Date

March 20, 2018

Last Update Submit

April 1, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • postoperative pain

    Subjects rated postoperative pain intensity using a visual analog scale (VAS) at 12, 24, and 48 hours after surgery. The scale was presented as a 10-cm line with verbal descriptors ranging from "no pain" to "worst imaginable pain".

    at 48 hours after surgery

Secondary Outcomes (2)

  • limitation of walking ability

    at 48 hours after surgery

  • Incentive spirometry performance

    at 24 hours after surgery

Study Arms (2)

Experimental group

EXPERIMENTAL

In subjects allocated to the abdominal binder group, the abdomen binder with a standard height of 22 cm (Sejung Korea, Seoul, Republic of Korea) was applied before leaving the operating room. The binder was placed on the abdomen across the laparoscopic incision, with the upper border not higher than the lower margin of the rib cage, ensuring minimal restriction of lateral costal expansion and diaphragmatic excursion. Subjects were carefully instructed to use the abdominal binder during at least the first 2 consecutive days and night, and to reposition the abdominal binder correctly when needed.

Device: Experimental group

Control group

PLACEBO COMPARATOR

In subjects allocated in the control group, subjects were not given any opportunity to ware an abdominal binder.

Device: Control group

Interventions

In subjects allocated to the abdominal binder group, the abdomen binder with a standard height of 22 cm (Sejung Korea, Seoul, Republic of Korea) was applied before leaving the operating room. The binder was placed on the abdomen across the laparoscopic incision, with the upper border not higher than the lower margin of the rib cage, ensuring minimal restriction of lateral costal expansion and diaphragmatic excursion. Subjects were carefully instructed to use the abdominal binder during at least the first 2 consecutive days and night, and to reposition the abdominal binder correctly when needed.

Experimental group

In subjects allocated in the control group, subjects were not given any opportunity to ware an abdominal binder.

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 18 and 65 years
  • American Society of Anesthesiologists physical status (ASAPS) classification I-II
  • absence of pregnancy at the time of surgery

You may not qualify if:

  • body mass index (BMI) ≥30 kg/m2
  • history of abdominal surgery within 6 months
  • history of ventral or incisional hernia
  • walking disabilities (or walking with the assistance of crutches or a walker)
  • chronic obstructive respiratory disease
  • stage IV cancer,
  • chronic pain syndrome (defined as daily intake of opioids for chronic back pain, chronic headache, or fibromyalgia)
  • inability to fill out the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kangbuk Samsung Hospital

Seoul, Jongno-gu, 03181, South Korea

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Taejong Song, MD PhD

    Kangbuk Samsung Hospital, Seoul, Republic of Korea

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 20, 2018

First Posted

April 2, 2018

Study Start

April 20, 2018

Primary Completion

August 5, 2018

Study Completion

October 31, 2018

Last Updated

April 3, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations